Explosive increase of Salmonella Java in poultry in the Netherlands: consequences for public health.
In the Netherlands Salmonella Paratyphi B variant Java increased in poultry from less than 2% of all isolates before 1996 to 60% in 2002. Despite exposure to contaminated meat is high, human patients with Java infection are rare (0.3% of all isolates). However, 50% of the human isolates showed PFGE profiles identical to the poultry clone. Resistance to flumequin in S. Java increased from 3% between 1996-2000 to 19% in 2001, and 39% in 2002, while that of other serotypes in poultry remained at about 7%. S. Java is also fast becoming less sensitive to ciprofloxacin.
van Pelt
W
W
van der Zee
H
H
Wannet
W J B
WJ
van de Giessen
A W
AW
Mevius
D J
DJ
Bolder
N M
NM
Komijn
R E
RE
van Duynhoven
Y T H P
YT
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones; D009426:Netherlands / Q000453:epidemiology; D011200:Poultry / Q000382:microbiology*; D011634:Public Health; D011807:Quinolizines / Q000627:therapeutic use; D012480:Salmonella Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission; D012484:Salmonella paratyphi B / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D012703:Serotyping
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D011807:Quinolizines; D002939:Ciprofloxacin; C012976:flumequine